Skip to main content
. 2015 Jun 29;6:651. doi: 10.3389/fmicb.2015.00651

FIGURE 2.

FIGURE 2

Survival of hamsters challenged s.c. with RVFV that received post-exposure treatment with rMP12-C13type or MP-12 vaccine strains. Animals in each group (n = 10) were treated s.c. with 1 × 105 PFU of rMP12-C13type, MP-12 or placebo at 8, 12, or 24 h post-infection. ***P < 0.001 compared to animals receiving the placebo. aP < 0.001, cP < 0.05 compared to animals treated with MP-12.